• DOI:10.1159/000055405
Corpus ID: 23123767

The Predictive Value of HER2 in Breast Cancer

@article{Piccart2001ThePV,
  title={The Predictive Value of HER2 in Breast Cancer},
  author={M. Piccart and C. Lohrisch and A. Di Leo and D. Larsimont},
  journal={Oncology},
  year={2001},
  volume={61},
  pages={73 - 82}
}

M. Piccart, C. Lohrisch, +1 author D. Larsimont

Published 2001

Medicine

Oncology

Measurement of molecular markers predictive of response to therapy should enable more selective and effective utilization of anticancer agents. The predictive value of HER2 remains a complex and inconclusive subject. In metastatic breast cancer, HER2-positive, ER-positive patients can show responses to endocrine treatment, but experience shorter time to progression and survival than HER2-negative patients. In the adjuvant setting, weak, retrospective evidence suggests that tamoxifen is… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed